Dolutegravir for second-line antiretroviral therapy

  • Main
  • 2019 / 2
  • Dolutegravir for second-line antiretroviral therapy
The Lancet Infectious Diseases 2019 / 2

Dolutegravir for second-line antiretroviral therapy

Hamers, Raph L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(19)30035-0
Date:
February, 2019
File:
PDF, 76 KB
2019
Conversion to is in progress
Conversion to is failed